Furthermore, comparative distribution of SSTR subtypes mRNA has also been made in glioma and medulloblastoma with comparable expression to control in medulloblastoma with high SSTR1 and least expression of SSTR5, whereas, in glioblastoma, expression was different, and tumors displayed high expression of SSTR3 and minimum expression of SSTR5 [122]. This evidence concerns the gene SSTR5 and central nervous system cancer.